PML and hepatocellular carcinoma: In hepatocellular carcinoma cells, IFNA treatment enhances the expression of promyelocytic leukemia (PML) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), activating the extrinsic apoptotic pathways that lead to cell death [19].